Pharmaceuticals, Biotechnology and Life Sciences
Opdivo plus Yervoy yielded objective response rate of 31% and median duration of response of 17.5 months Data demonstrate potential…
STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases…
New Clinical Data Presented Today Included in Recently Submitted NDA to FDA CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage…
NEW YORK–(BUSINESS WIRE)–#ChildhoodCancerAwareness–Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces today its partnership…
Key linker element of Avacta’s novel TMAC™ drug conjugate to be tested in humans within 12 months CAMBRIDGE, England–(BUSINESS WIRE)–Avacta…
BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma, a global leader in medical dermatology, today announced that Gitte Aabo will step down as President…
HONG KONG–(BUSINESS WIRE)–Great Bay Bio, a leading biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical…
CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge–Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications has closed a further round…
New analyses from first-in-human clinical trial presented at the 2019 ASCO Annual Meeting Pivotal trials in metastatic uveal melanoma are…
Alecensa reduced the risk of disease progression or death by 63% compared to crizotinib Long-term follow-up reconfirmed that Alecensa prolonged…